Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma

Neurologia i Neurochirurgia Polska

Volumn 42, Issue 4, 2008, Pages 362-365

  Hakan, Tayfun ^a,b   Aker, Fugen Vardar ^a  

^a Haydarpasa Numune Teaching and Research Hospital   (Turkey)

^b Acibadem Gomec Sokak A Blok 27/11   (Turkey)

Author keywords

Cystic glioblastoma; Glioblastoma; Neurofibromatosis type 1; Neurofibromin; Temozolomide

Indexed keywords

ANTINEOPLASTIC AGENT; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CRANIOTOMY; DEATH; FEMALE; GLIOBLASTOMA; HEADACHE; HUMAN; HUMAN TISSUE; MULTIMODALITY CANCER THERAPY; NEUROFIBROMATOSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; POSTOPERATIVE PERIOD;

ADULT; BRAIN NEOPLASMS; FATAL OUTCOME; FEMALE; FRONTAL LOBE; GLIOBLASTOMA; HUMANS; NEUROFIBROMATOSIS 1;

EID: 56649117350     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gutmann D.H., James C.D., Poyhonen M., et al. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology 2003; 61: 1397-1400.
2. Hariharan S., Donahue J.E., Garre C., et al. Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomas. J Neurol Sci 2006; 247: 105-108.
3. Kroh H., Matyja E., Marchel A., et al. Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1 (NF1): report of a case with long-term survival. Clin Neuropathol 2004; 23: 286-291.
4. Riffaud L., Vinchon M., Ragragui O., et al. Hemispheric cerebral gliomas in children with NF1: arguments for a long-term follow-up. Childs Nerv Syst 2002; 18: 43-47.
5. Guillamo J.S., Créange A., Kalifa C., et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 2003; 126: 152-160.
6. Zöller M.E., Rembeck B., Odén A., et al. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997; 79: 2125-2131.
7. Deimling A., Krone W. Neurofibromatosis type 1. In: Kleihues P., Cavenee W. K. [eds.]. Pathology and Genetics of Tumours of Nervous System. IARC Press, Lyon 2000, pp. 172-174.
8. Gutmann D.H., Rasmussen S.A., Wolkenstein P., et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 2002; 59: 759-761.
9. Listernick R., Ferner R.E., Liu G.T., et al. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61: 189-298.
10. Distelmaier F., Fahsold R., Reifenberger G., et al. Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up. Childs Nerv Syst 2007; 23: 343-347.
11. Miyata S., Sugimoto T., Kodama T., et al. Adenoid glioblastoma arising in a patient with neurofibromatosis type-I. Pathol Int 2005; 55: 348-352.
12. Elmaci I., Kurtkaya O., Boran B., et al. Gliosarcoma associated with neurofibromatosis type I: a case report. Tumori 2001; 87: 60-63.
13. Nicholas M.K. Glioblastoma multiforme: evidence-based approach to therapy. Expert Rev Anticancer Ther 2007; 7 (12 Suppl): S23-27.
14. Maldaun M.V., Suki D., Lang F.F., et al. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg 2004; 100: 61-67.
15. Dehdashti A.R., Hegi M.E., Regli L., et al. New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy. Neurosurg Focus 2006; 20: E6.